Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan.
Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan.
Transfus Med Rev. 2014 Jan;28(1):1-6. doi: 10.1016/j.tmrv.2013.10.002. Epub 2013 Oct 19.
Hemolytic disease of the fetus and newborn (HDFN) attributed to M/N-incompatibility varies from asymptomatic to lethally hydropic. Case reports are rare, and the clinical significance of anti-M is not completely understood. A challenging case of HDFN due to anti-M prompted an investigation of the Japanese literature, in order to characterize the clinical spectrum of M/N-incompatibility pregnancies in Japan and report results to English-language readers. Japanese reports of HDFN attributed to M/N incompatibility were compiled. Abstracted data include maternal antibody titers at delivery, fetal direct antiglobulin test, hemoglobin, total bilirubin, reticulocyte count at birth, and therapeutic interventions. We investigated characteristics of HDFN due to M/N-incompatible pregnancies in Japan after encountering a case of severe HDFN along with late-onset anemia in an infant born to a woman carrying IgG anti-M with a titer of 1. In total, thirty-three babies with HDFN due to anti-M and one due to anti-N have been reported in Japan since 1975. The median maternal antibody titer was 64 at delivery and was 16 or less in 10 of 34 women (29%). Five of 34 babies (15%) were stillborn or died as neonates. Twenty-one of 29 survivors (72%) had severe hemolytic anemia and/or hydrops fetalis. The reticulocyte count of neonates with anemia stayed below the reference interval. Sixteen (55%) developed late-onset anemia and 14 (48%) were transfused with M-negative RBCs. Significant positive correlation (P < .05) between the hemoglobin value and the reticulocyte count within 4 days of birth was obtained in 16 babies with anti-M HDFN. In the Japanese population, 21 of 34 cases of M/N-incompatible HDFN (72%) have manifested as severe hemolytic anemia and/or hydrops fetalis. Low reticulocyte count in neonates with late-onset anemia is consistent with suppressed erythropoiesis due to anti-M.
胎儿和新生儿溶血病(HDFN)归因于 M/N 不相容性的范围从无症状到致命的水肿。病例报告很少,抗-M 的临床意义尚未完全了解。由于抗-M 导致的 HDFN 挑战性病例促使我们对日本文献进行了调查,以便描述日本 M/N 不相容性妊娠的临床谱,并向英语读者报告结果。编译了归因于 M/N 不相容性的 HDFN 的日本病例报告。提取的数据包括分娩时的母体抗体效价、胎儿直接抗球蛋白试验、血红蛋白、总胆红素、出生时的网织红细胞计数以及治疗干预措施。在遇到一例抗-M 导致的严重 HDFN 以及一名携带 IgG 抗-M 滴度为 1 的女性所生婴儿出现迟发性贫血后,我们调查了日本因 M/N 不相容性妊娠导致的 HDFN 的特征。自 1975 年以来,日本共报告了 33 例抗-M 导致的 HDFN 婴儿和 1 例抗-N 导致的 HDFN 婴儿。分娩时母体抗体效价中位数为 64,34 名女性中有 10 名(29%)效价为 16 或更低。5 名婴儿(15%)为死产或新生儿死亡。29 名幸存者中有 21 名(72%)患有严重溶血性贫血和/或胎儿水肿。贫血新生儿的网织红细胞计数低于参考区间。16 名(55%)出现迟发性贫血,14 名(48%)接受 M 阴性 RBC 输血。在 16 例抗-M HDFN 婴儿中,出生后 4 天内血红蛋白值与网织红细胞计数之间获得了显著正相关(P<.05)。在日本人群中,34 例 M/N 不相容性 HDFN 中有 21 例(72%)表现为严重溶血性贫血和/或胎儿水肿。迟发性贫血新生儿网织红细胞计数低与抗-M 抑制红细胞生成一致。